CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
3.39
1.17%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.15
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 3.43
Open* 3.38
1-Year Change* -30.88%
Day's Range* 3.38 - 3.47
52 wk Range 4.05-6.20
Average Volume (10 days) 26.41K
Average Volume (3 months) 883.02K
Market Cap 47.93M
P/E Ratio -100.00K
Shares Outstanding 10.87M
Revenue N/A
EPS -1.31
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Nov 6, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 3.39 0.00 0.00% 3.39 3.50 3.38
Sep 28, 2023 3.43 -0.21 -5.77% 3.64 3.65 3.38
Sep 27, 2023 3.73 0.01 0.27% 3.72 3.81 3.67
Sep 26, 2023 3.47 -0.08 -2.25% 3.55 3.65 3.32
Sep 25, 2023 3.48 -0.31 -8.18% 3.79 3.79 3.32
Sep 22, 2023 3.63 -0.05 -1.36% 3.68 3.73 3.63
Sep 21, 2023 3.68 -0.06 -1.60% 3.74 3.85 3.68
Sep 20, 2023 3.81 -0.02 -0.52% 3.83 3.87 3.73
Sep 19, 2023 3.88 0.05 1.31% 3.83 3.91 3.83
Sep 18, 2023 3.84 -0.12 -3.03% 3.96 3.98 3.83
Sep 15, 2023 3.99 -0.13 -3.16% 4.12 4.14 3.93
Sep 14, 2023 4.13 -0.09 -2.13% 4.22 4.23 4.08
Sep 13, 2023 4.24 0.04 0.95% 4.20 4.35 4.19
Sep 12, 2023 4.22 -0.16 -3.65% 4.38 4.38 4.19
Sep 11, 2023 4.31 -0.09 -2.05% 4.40 4.40 4.31
Sep 8, 2023 4.40 0.01 0.23% 4.39 4.48 4.39
Sep 7, 2023 4.32 0.04 0.93% 4.28 4.32 4.28
Sep 6, 2023 4.30 -0.09 -2.05% 4.39 4.39 4.23
Sep 5, 2023 4.44 -0.15 -3.27% 4.59 4.60 4.38
Sep 1, 2023 4.54 0.09 2.02% 4.45 4.64 4.38

Lantern Pharma Inc. Events

Time (UTC) Country Event
Monday, November 6, 2023

Time (UTC)

10:59

Country

US

Event

Q3 2023 Lantern Pharma Inc. Earnings Release
Q3 2023 Lantern Pharma Inc. Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 14.4327 12.4825 5.90819 2.42819 1.72642
Selling/General/Admin. Expenses, Total 5.8298 5.02093 3.66497 1.475 1.15432
Research & Development 8.60295 7.57058 2.24323 0.95319 0.5721
Operating Income -14.4327 -12.4825 -5.90819 -2.42819 -1.72642
Net Income Before Taxes -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Net Income After Taxes -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Net Income Before Extra. Items -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Net Income -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Income Available to Common Excl. Extra. Items -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Income Available to Common Incl. Extra. Items -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Diluted Net Income -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Diluted Weighted Average Shares 10.8506 10.9049 6.22093 6.03059 6.03059
Diluted EPS Excluding Extraordinary Items -1.31421 -1.13371 -0.94973 -0.40264 -0.28628
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.31421 -1.14371 -0.94973 -0.40264 -0.28628
Unusual Expense (Income) -0.109
Interest Income (Expense), Net Non-Operating 0.20436 0.11948
Other, Net -0.03155
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 0 0 0 0 0
Total Operating Expense 4.28627 3.82628 2.14526 4.39482 4.0664
Selling/General/Admin. Expenses, Total 1.73332 1.57468 1.44296 1.406 1.40616
Research & Development 2.55295 2.2516 0.7023 2.98882 2.66024
Operating Income -4.28627 -3.82628 -2.14526 -4.39482 -4.0664
Net Income Before Taxes -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Net Income After Taxes -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Net Income Before Extra. Items -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Net Income -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Income Available to Common Excl. Extra. Items -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Income Available to Common Incl. Extra. Items -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Diluted Net Income -3.86777 -3.38111 -2.26468 -4.49239 -4.12177
Diluted Weighted Average Shares 10.857 10.8571 10.8389 10.8309 10.8758
Diluted EPS Excluding Extraordinary Items -0.35624 -0.31142 -0.20894 -0.41477 -0.37899
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.35624 -0.31142 -0.20894 -0.41477 -0.37899
Unusual Expense (Income)
Interest Income (Expense), Net Non-Operating 0.13378 0.07468 0.05222 0.05503 0.02242
Other, Net 0.28472 0.37049 -0.17165 -0.15259 -0.0778
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 58.7227 72.7164 20.2369 1.23282 0.44516
Cash and Short Term Investments 55.1961 70.7254 19.2292 1.23203 0.44516
Cash 37.2018 51.5243 19.2292 1.23203 0.44516
Total Assets 58.8363 73.9505 20.3596 1.43258 0.44983
Property/Plant/Equipment, Total - Net 0.0957 0.21619 0.02151 0.00876 0.00467
Other Long Term Assets, Total 0.01789 1.01789 0.10121 0.191 0
Total Current Liabilities 2.7983 2.32617 0.55234 0.48929 0.65163
Payable/Accrued 2.74541 2.17411 0.55234 0.48929 0.11663
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.535
Total Liabilities 2.7983 2.37906 0.66084 0.48929 0.65163
Total Long Term Debt 0 0 0.1085 0 0
Total Equity 56.038 71.5714 19.6988 0.94328 -0.2018
Redeemable Preferred Stock 0.01402 0.00743
Common Stock 0.00109 0.00111 0.00062 0.01137 0.01137
Additional Paid-In Capital 95.6912 96.6859 32.3581 7.6696 4.10292
Retained Earnings (Accumulated Deficit) -39.2829 -25.0229 -12.6599 -6.75171 -4.32352
Total Liabilities & Shareholders’ Equity 58.8363 73.9505 20.3596 1.43258 0.44983
Total Common Shares Outstanding 10.857 11.0888 6.22093 6.03059 6.03059
Prepaid Expenses 2.98547 1.99095 1.00769 0.00079
Long Term Debt 0 0.1085
Short Term Investments 17.9943 19.2012
Accrued Expenses 0.05289 0.15206
Other Liabilities, Total 0 0.05289
Other Equity, Total -0.37139 -0.09269
Other Current Assets, Total 0.54118
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 55.1676 58.7227 62.0198 65.663 67.6632
Cash and Short Term Investments 51.5401 55.1961 57.8266 62.1495 65.2165
Cash 32.4788 37.2018 39.2579 43.3629 46.6517
Prepaid Expenses 3.08633 2.98547 3.65197 3.51349 2.44668
Total Assets 55.5093 58.8363 62.1644 66.3798 68.4025
Property/Plant/Equipment, Total - Net 0.30879 0.0957 0.12673 0.15775 0.18029
Other Long Term Assets, Total 0.03297 0.01789 0.01789 0.55907 0.55907
Total Current Liabilities 2.79319 2.7983 3.139 5.30429 3.07385
Payable/Accrued 2.6736 2.74541 3.04697 5.17359 2.91865
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 2.93382 2.7983 3.139 5.30429 3.08715
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Total Equity 52.5755 56.038 59.0254 61.0755 65.3154
Common Stock 0.00109 0.00109 0.00109 0.00108 0.00108
Additional Paid-In Capital 96.0247 95.6912 95.3611 95.06 94.7705
Retained Earnings (Accumulated Deficit) -43.1506 -39.2829 -35.9018 -33.6371 -29.1447
Total Liabilities & Shareholders’ Equity 55.5093 58.8363 62.1644 66.3798 68.4025
Total Common Shares Outstanding 10.857 10.857 10.857 10.8309 10.8309
Short Term Investments 19.0613 17.9943 18.5687 18.7866 18.5648
Accrued Expenses 0.11958 0.05289 0.09202 0.13071 0.15519
Other Current Liabilities, Total
Other Liabilities, Total 0.14063 0 0 0 0.0133
Other Equity, Total -0.29968 -0.37139 -0.43504 -0.34848 -0.31147
Other Current Assets, Total 0.54118 0.54118 0.54118
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -14.2599 -12.363 -5.90819 -2.42819 -1.72642
Cash From Operating Activities -12.7675 -10.5915 -5.65162 -2.12792 -1.27152
Non-Cash Items 2.09424 1.16477 1.19224 0.11776 0.18306
Changes in Working Capital -0.61186 0.59996 -0.93906 0.18088 0.27184
Cash From Investing Activities 0.17927 -19.5306 -0.01614 -0.00572 0.00534
Other Investing Cash Flow Items, Total 0.20711 -19.5151 0.00534
Cash From Financing Activities -2.1825 63.4161 23.665 2.92051 0.535
Financing Cash Flow Items 0 -4.78382 -2.74554 0 0.535
Issuance (Retirement) of Stock, Net -2.1825 68.1999 26.302 2.92051 0
Net Change in Cash -14.7813 33.2951 17.9972 0.78687 -0.73118
Cash From Operating Activities 0.01008 0.00676 0.00339 0.00163
Capital Expenditures -0.02784 -0.0155 -0.01614 -0.00572
Issuance (Retirement) of Debt, Net 0 0.1085
Foreign Exchange Effects -0.01061 0.00107
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -3.86777 -14.2599 -10.8788 -8.61416 -4.12177
Cash From Operating Activities -3.75716 -12.7675 -10.0986 -6.06036 -3.32773
Cash From Operating Activities 0.00342 0.01008 0.00732 0.00437 0.00199
Non-Cash Items 0.34754 2.09424 1.76509 1.16612 0.5284
Changes in Working Capital -0.24035 -0.61186 -0.9922 1.3833 0.26366
Cash From Financing Activities 0 -2.1825 -2.1825 -2.1825 -2.1825
Financing Cash Flow Items 0 0 0 0
Issuance (Retirement) of Stock, Net 0 -2.1825 -2.1825 -2.1825 -2.1825
Issuance (Retirement) of Debt, Net
Net Change in Cash -4.72302 -14.7813 -12.7252 -8.62025 -5.33143
Cash From Investing Activities -0.96088 0.17927 -0.42359 -0.34923 0.17652
Capital Expenditures -0.00888 -0.02784 -0.02089 -0.01418
Other Investing Cash Flow Items, Total -0.952 0.20711 -0.4027 -0.33505 0.17652
Foreign Exchange Effects -0.00498 -0.01061 -0.02051 -0.02816 0.00228
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Bios Equity Partners, LP. Venture Capital 14.1044 1533018 -323907 2023-04-15 LOW
Biological Mimetics, Inc Corporation 8.6894 944458 -13807 2023-04-15 LOW
Prophase Labs Inc Corporation 8.3724 910000 0 2023-04-15 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.3807 367454 0 2023-06-30 LOW
GWM Advisors LLC Investment Advisor 1.5776 171465 -650 2023-06-30 LOW
Carlson Capital, L.P. Hedge Fund 0.874 95000 -29900 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8283 90026 32252 2023-06-30 LOW
CM Management, LLC Investment Advisor 0.69 75000 15000 2023-06-30 LOW
Redmond Asset Management, LLC Investment Advisor 0.4288 46604 -2585 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.4131 44900 20300 2023-06-30 HIGH
Keyser (Donald Jeffrey PH.D) Individual Investor 0.3857 41927 0 2023-04-15 LOW
Horizon Kinetics LLC Investment Advisor/Hedge Fund 0.276 30000 0 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2553 27752 0 2023-06-30 LOW
UBS Financial Services, Inc. Investment Advisor 0.2484 27000 0 2023-06-30 LOW
Newton Investment Management North America, LLC Investment Advisor 0.2436 26480 0 2023-06-30 MED
WWM Financial Investment Advisor 0.2313 25145 -1333 2023-06-30 LOW
Citadel Advisors LLC Hedge Fund 0.2276 24737 13761 2023-06-30 LOW
Incrementum AG Investment Advisor 0.1738 18888 0 2023-06-30 MED
Sigma Planning Corporation Investment Advisor 0.1668 18125 850 2023-06-30 LOW
Commonwealth Financial Network Investment Advisor 0.1547 16813 -3373 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Lantern Pharma Inc. Company profile

About Lantern Pharma Inc.

Lantern Pharma Inc. is a clinical stage biopharmaceutical company. The Company is focused on leveraging artificial intelligence (AI), machine learning and genomic data to streamline the drug development process and to identify the patients, which benefits from its targeted oncology therapies. The Company’s therapies portfolio consists of small molecule drug candidates and new compounds, which it is developing with the assistance of its AI platform and its biomarker driven approach. The Company’s AI platform, RADR uses big data analytics, including combining molecular data, drug efficacy data, data from historical studies, data from scientific literature, phenotypic data from trials and publications, and mechanistic pathway data, and machine learning. The Company’s data-driven, gnomically targeted and biomarker-driven approach allows it to pursue a transformational drug development strategy, which identifies, rescues or develops, and advances potential small molecule drug candidates.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Lantern Pharma Inc. revenues was not reported. Net loss increased from $5.9M to $12.4M. Higher net loss reflects Research and development increase from $2.2M to $7.6M (expense), General and administrative - Balancing v increase of 99% to $4.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.95 to -$1.13.

Industry: Biotechnology & Medical Research (NEC)

1920 Mckinney Avenue
7th Floor
DALLAS
TEXAS 75201
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

ETH/USD

1,678.32 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

XRP/USD

0.52 Price
+0.020% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Oil - Crude

90.04 Price
-1.230% 1D Chg, %
Long position overnight fee 0.0661%
Short position overnight fee -0.0881%
Overnight fee time 21:00 (UTC)
Spread 0.030

US100

14,744.20 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading